Home › Uterine Cancer › Pennsylvania › Harrisburg
Uterine Cancer clinical trials in Harrisburg, PA
3 studies for Uterine Cancer are looking for participants at sites in and around Harrisburg (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
RecruitingPhase 4
- PinnacleHealth Women´s Cancer Center (Ortenzio Cancer Center), Mechanicsburg · 8 mi away
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
RecruitingPhase 3
- Research Site, Hershey · 12 mi away
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
RecruitingPhase 3
- Research Site, Hershey · 12 mi away
About Uterine Cancer
Uterine cancer is a cancer that forms in tissues of the uterus. It is more likely to happen after menopause. There are things you can do that may help lower your risk.
More about Uterine Cancer on MedlinePlus
Uterine Cancer trials in other cities
- Houston, TX8 studies
- New York City, NY7 studies
- Boston, MA7 studies
- Columbus, OH6 studies
- Austin, TX6 studies
- Philadelphia, PA6 studies
- Miami, FL5 studies
- Nashville, TN5 studies
- Orlando, FL4 studies
- Pittsburgh, PA4 studies
- West Palm Beach, FL4 studies
- Providence, RI4 studies
Other studies in Harrisburg
- Heart Failure15 studies
- Non-Small Cell Lung Cancer12 studies
- Cardiovascular Disease12 studies
- Breast Cancer11 studies
- Neuroblastoma8 studies
- Lung Cancer8 studies
- Prostate Cancer8 studies
- Acute Myeloid Leukemia8 studies
- Colorectal Cancer7 studies
- Head and Neck Squamous Cell Carcinoma7 studies
- Crohn's Disease6 studies
- High Blood Pressure6 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.